The Transfusion News email arrived in my in-box
this morning. All good stuff…
![]() Previous studies have reported that restrictive transfusion strategies are non-inferior compared to liberal strategies for cardiac surgery patients followed up to 90 days after surgery. Results from the Transfusion Requirements in Cardiac Surgery (TRICS) III trial, which examined six-month outcomes for cardiopulmonary bypass patients at a moderate to high risk [Read More] |
|||
![]() Patients with liver failure receive almost 1 in every 5 blood products transfused in hospitals! Jeannie Callum thinks that’s too much, and she shows us how to improve practice in these complex patients. [Listen Now] |
|||
|
|||
![]() Hematopoietic stem cell (HSC) transplants can be life saving for many patients, including those with immune disorders, certain types of cancers, blood disorders, and some genetic conditions. However, HLA-matching for bone marrow HSC transplants can be difficult, and allogenic transplants can lead to graft vs. host disease. Transplantation using cord [Read More] |
No comments:
Post a Comment